| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Biotechnology (IBB) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Biotechnology sector is very positive (overall 2.9, positive 3.5, negative -0.7) on 20251016. The forces of Sentiment towards Fundamentals (3.2), Price Level (2), Option Speculation (1.5), Sector Price Trend (0.3), and Broad Market Trend (-0.3) will drive up the price. The forces of Valuation Sentiment (-1), and Market Risk Prefrence (0) will drive down the price. 'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.5). The extreme bullish overall sentiment (2.9) may signal the top of this uptrend. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on IBB trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Fundamentals | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-16 | 0% | 0% | 153.42 | 82 | 0.02% | 0.26% | 1.2 | 0.3 | 3.2 | 7 |
| 2025-10-15 | 0% | 0.1% | 153.39 | 86 | 1.37% | 0.33% | 1.2 | 0.3 | 2.9 | 6.5 |
| 2025-10-14 | 0% | 0.1% | 151.32 | 78 | 0.25% | 0.47% | 1.5 | 0.9 | 3.1 | 0 |
| 2025-10-13 | 0% | 0.1% | 150.94 | 79 | 0.66% | 0.54% | 1.2 | 0.9 | 2.8 | 8 |
| 2025-10-12 | 0% | 0.1% | 1.4 | 0.5 | 2.7 | 0 | ||||
| 2025-10-11 | 0% | 0.1% | 1.4 | 0.5 | 2.7 | 0 | ||||
| 2025-10-10 | 0% | 0.1% | 149.95 | 76 | -1.38% | 0.61% | 1.2 | 0.5 | 2.2 | 0 |
| 2025-10-09 | 1% | 0.1% | 152.05 | 91 | 0.04% | 0.88% | 2.4 | 1.2 | 2.9 | 4.3 |
| 2025-10-08 | 0% | 0% | 151.99 | 96 | 1% | 0.69% | 2.7 | 1.2 | 3.1 | 8 |
| 2025-10-07 | 0% | 0% | 150.48 | 94 | -0.03% | 0.55% | 2.4 | 1.2 | 2.8 | 0 |
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (7) Cellectis Shares Rise 8% On Phase 2 Trial Update For Lasme-cel Cellectis S.A. (CLLS) shares climbed 7.35 percent to $4.41, gaining $0.30 on Thursday, after the biotechnology company announced it is hosting an R&D Day in New York City. (https://www.rttnews.com/) Thu. Oct 16, 2025 | |
| 2 (6) After a low period, biotech stocks are on the upswing, experts say After a period of weakness, biotech stocks are on the upswing, experts say. But bear in mind: Putting your money into biotechnology companies can lead you on (https://www.thestreet.com/) Wed. Oct 15, 2025 | |
| 3 (7) Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments (https://www.marketbeat.com/) Wed. Oct 15, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA